| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.05 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.087 | 0.05 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | 0.061 | 0.05 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.069 | 0.05 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.05 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | -0.061 | 0.05 |
| mRNA | KIN001-244 | GDSC1000 | pan-cancer | AAC | -0.06 | 0.05 |
| mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | 0.099 | 0.05 |
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | -0.065 | 0.05 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.082 | 0.05 |